Get 40% Off
🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

4 Stocks To Watch: BLOX, DRNA, ITCI, SGMO

Published 12/01/2015, 11:51 PM
Updated 07/09/2023, 06:31 AM
NVDA
-
NEGG
-
IDTI
-
MXWL
-
SGMO
-
BLOX
-
LOCK
-
LGIH
-
WUBA
-
RLYP
-
VUZI
-
ITCI
-
DRNA
-
ATEN
-
GBIM
-
TERP_old
-
NVRO
-

It was a really interesting day on Wall Street on Tuesday. There was a big surge at the opening, a large consolidation-type wedge, and then at the end of the day they tried to rally, and did a good job of doing that, and finishing at the highs for the day. That was a positive session for Wall Street. A lot of stocks that we follow did well. Let’s take a look at some old ones, new ones, and some swing trades, and see how they are doing.

Infoblox Inc. (N:BLOX) had been on our Top 25 for the year, and did very, very well until it rolled over, going from 28 all the way down to 13. It did turn around with a break away gap, and popped 3.31 to 18.35, or 22%, on 6.8 million shares on Tuesday. With 6.23 days to cover, it looks like it’s going to extend to 20-20 1/2, and maybe 22. Those are the targets going forward.

Dicerna Pharmaceuticals, Inc. (O:DRNA) has a very impressive pattern. It ran up, rolled over, came down in a nice declining channel with a left shoulder-head-right shoulder, pulled back in an orderly fashion, and stair-stepped its way higher for the last six days. It popped out of the neckline on Tuesday, up 1.11 to 14.47, or 8.3%, on only 125,300 shares traded. That is average volume for this stock. It has 8.43 days to cover. But the inverse head-and-shoulder pattern was broken at the neckline. Look for a quick test of the 15-15 1/4 zone, and then maybe 18. Those are the targets for DRNA.

Intra-Cellular Therapies, Inc. (O:ITCI) has an interesting chart. After the explosive move in September, and then the pullback, it’s been moving up steadily for a couple months. It pulled back on Monday, but it reversed and was back up again on Tuesday, up 2.39 to 55.72, or 4.48%, on 493,500 shares traded. As long as it holds that line it will be good. Don’t let it get under 47 1/2. That's the stopping point. If it takes off, this stock could run up to the mid 70’s.

Sangamo Biosciences Inc. (O:SGMO) is looking good. The major declining channel broke in Oct, it moved up, formed a falling wedge, and then the OBV spiked up on volume on Tuesday as it broke out 94 cents to 9.22, or 11.4%, on 2.5 million shares. That’s the best volume in weeks. If it can get through 9.40-.50, it should see 11.00 short-term.

Other stocks on the long side include A10 Networks, Inc. (N:ATEN), Dehaier Medical Systems Limited (O:DHRM), GlobeImmune Inc. (O:GBIM), Integrated Device Technology, Inc. (O:IDTI), LGI Homes, Inc. (O:LGIH), LifeLock, Inc. (N:LOCK), Maxwell Technologies, Inc. (O:MXWL), NVIDIA Corporation (O:NVDA), Nevro Corp. (N:NVRO), Relypsa, Inc. (O:RLYP), TerraForm Power, Inc. (O:TERP), Vuzix Corporation (O:VUZI), and 58.com Inc. (N:WUBA).

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.